Danaher Corporation (DHR)

223,31 +0,79 (+0,36 %) À la clôture : 04:03PM EST

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 79 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Steven M. Rales	Co-Founder & Chairman	S.O.	S.O.	1951
Mr. Rainer M. Blair	President, CEO & Director	5,93M	5,83M	1964
Mr. Mitchell P. Rales	Co-Founder & Director	S.O.	S.O.	1957
Mr. Matthew R. McGrew	CFO & Executive VP	2,85M	4,12M	1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Senior VP & Chief Science Officer	2,24M	S.O.	1963
Mr. Joakim Weidemanis	Executive Vice President	3,13M	6,28M	1969
Mr. Christopher M. Bouda	VP & Chief Accounting Officer	S.O.	S.O.	S.O.
Mr. John Bedford	Vice President of Investor Relations	S.O.	S.O.	S.O.
Mr. Brian W. Ellis	Senior VP, General Counsel & Chief Compliance Officer	1,93M	S.O.	1967
Mr. Daniel A. Raskas J.D.	Senior Vice President of Corporate Development	S.O.	S.O.	1967

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Danaher Corporation en date du 28 novembre 2023 est 7. Les scores principaux sont Audit : 8; Société : 10; Droits des actionnaires : 3; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.